This study now being published in The Journal of Nutritional Biochemistry details the exceptional ability of resveratrol to stimulate estrogen receptors in a way that can alleviate the effects of estrogen deficiency while at the same time protecting against breast cancer. We have been using a laboratory-certified form of reseveratol for its previously documented effects on insulin, leptin and glucose regulation (it has also extended the lifespan of lab animals—it’s the component in red wine that has been well-publicized). The authors state: “Thus, resveratrol might be the most promising candidate for HRT and chemoprevention of breast cancer due to its estrogenic activity and high antitumor activity.”

-

Thyroid function is critical during every stage of life  but is especially vulnerable at menopause. As this paper from the journal of the International Society of Gynecological Endocrinology states: “The symptoms of thyroid disease can be similar to postmenopausal complaints and are clinically difficult to differentiate…It is of importance that even mild thyroid failure can have a number of clinical effects such as depression, memory loss, cognitive impairment and a variety of neuromuscular complaints…There is also an increased cardiovascular risk.” Inadequate assessment and calibration of estrogen support is another menopausal hazard for the thyroid as this research concludes: “Low estrogen level may lead to mild thyroidal hypofunction while estradiol treatment may lead to hyperactivity so it should be used very cautiously in the treatment of postmenopausal symptoms to avoid its undesirable stimulatory effect on the thyroid.”

-